Cargando…
Niclosamide Is a Proton Carrier and Targets Acidic Endosomes with Broad Antiviral Effects
Viruses use a limited set of host pathways for infection. These pathways represent bona fide antiviral targets with low likelihood of viral resistance. We identified the salicylanilide niclosamide as a broad range antiviral agent targeting acidified endosomes. Niclosamide is approved for human use a...
Autores principales: | Jurgeit, Andreas, McDowell, Robert, Moese, Stefan, Meldrum, Eric, Schwendener, Reto, Greber, Urs F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3486884/ https://www.ncbi.nlm.nih.gov/pubmed/23133371 http://dx.doi.org/10.1371/journal.ppat.1002976 |
Ejemplares similares
-
An RNA replication-center assay for high content image-based quantifications of human rhinovirus and coxsackievirus infections
por: Jurgeit, Andreas, et al.
Publicado: (2010) -
Novel Antiviral Activities of Obatoclax, Emetine, Niclosamide, Brequinar, and Homoharringtonine
por: Andersen, Petter I., et al.
Publicado: (2019) -
Plausible mechanisms of Niclosamide as an antiviral agent against COVID-19
por: Pindiprolu, Sai Kiran S.S., et al.
Publicado: (2020) -
The antiparasitic drug niclosamide inhibits dengue virus infection by interfering with endosomal acidification independent of mTOR
por: Kao, Jo-Chi, et al.
Publicado: (2018) -
Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission
por: Wang, Yu-Ming, et al.
Publicado: (2016)